Somatropin
Common brands: Genotropin, Omnitrope, Humatrope, Norditropin, Serostim
Top reporter: Pfizer Laboratories Div Pfizer Inc
Recombinant Human Growth Hormone [EPC]Corticosteroid [EPC]Androgen [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]
70,976
Total Reports
45,506
Serious Reports
1,491
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.10%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Somatropin.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DRUG DOSE OMISSION BY DEVICE | 17,455 | |
| 2 | DEVICE LEAKAGE | 10,157 | |
| 3 | DEVICE BREAKAGE | 9,089 | |
| 4 | DEVICE MECHANICAL ISSUE | 7,251 | |
| 5 | DEVICE INFORMATION OUTPUT ISSUE | 6,042 | |
| 6 | DEVICE ISSUE | 5,413 | |
| 7 | WRONG TECHNIQUE IN DEVICE USAGE PROCESS | 4,890 | |
| 8 | INJECTION SITE PAIN | 3,639 | |
| 9 | POOR QUALITY DEVICE USED | 3,205 | |
| 10 | DEVICE USE ERROR | 3,131 | |
| 11 | INCORRECT DOSE ADMINISTERED | 2,784 | |
| 12 | DEVICE PHYSICAL PROPERTY ISSUE | 2,755 | |
| 13 | INCORRECT DOSE ADMINISTERED BY DEVICE | 2,726 | |
| 14 | DEVICE USE ISSUE | 2,725 | |
| 15 | DEVICE MALFUNCTION | 2,300 | |
| 16 | HEADACHE | 2,184 | |
| 17 | DEVICE DELIVERY SYSTEM ISSUE | 2,175 | |
| 18 | DEVICE DEFECTIVE | 2,024 | |
| 19 | OFF LABEL USE | 2,009 | |
| 20 | PRODUCT DOSE OMISSION ISSUE | 1,795 | |
| 21 | DEVICE POWER SOURCE ISSUE | 1,465 | |
| 22 | EXPIRED DEVICE USED | 1,445 | |
| 23 | DEVICE DIFFICULT TO USE | 1,387 | |
| 24 | FATIGUE | 1,263 | |
| 25 | DEVICE FAILURE | 1,152 | |
| 26 | PRODUCT PRESCRIBING ERROR | 1,132 | |
| 27 | DRUG INEFFECTIVE | 1,092 | |
| 28 | INJECTION SITE HAEMORRHAGE | 1,082 | |
| 29 | INJECTION SITE BRUISING | 1,076 | |
| 30 | MALAISE | 1,051 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.